PMID- 21621458
OWN - NLM
STAT- MEDLINE
DCOM- 20120511
LR  - 20161020
IS  - 1878-1861 (Electronic)
IS  - 1878-1861 (Linking)
VI  - 15
IP  - 1
DP  - 2012 Jan
TI  - Exercise prescription for patients with type 2 diabetes and pre-diabetes: a 
      position statement from Exercise and Sport Science Australia.
PG  - 25-31
LID - 10.1016/j.jsams.2011.04.005 [doi]
AB  - Type 2 diabetes mellitus (T2DM) and pre-diabetic conditions such as impaired 
      fasting glucose (IFG) and/or impaired glucose tolerance (IGT) are rapidly 
      increasing in prevalence. There is compelling evidence that T2DM is more likely 
      to develop in individuals who are insufficiently active. Exercise training, often 
      in combination with other lifestyle strategies, has beneficial effects on 
      preventing the onset of T2DM and improving glycaemic control in those with 
      pre-diabetes. In addition, exercise training improves cardiovascular risk 
      profile, body composition and cardiorespiratory fitness, all strongly related to 
      better health outcomes. Based on the evidence, it is recommended that patients 
      with T2DM or pre-diabetes accumulate a minimum of 210 min per week of 
      moderate-intensity exercise or 125 min per week of vigorous intensity exercise 
      with no more than two consecutive days without training. Vigorous intensity 
      exercise is more time efficient and may also result in greater benefits in 
      appropriate individuals with consideration of complications and 
      contraindications. It is further recommended that two or more resistance training 
      sessions per week (2-4 sets of 8-10 repetitions) should be included in the total 
      210 or 125 min of moderate or vigorous exercise, respectively. It is also 
      recommended that, due to the high prevalence and incidence of comorbid conditions 
      in patients with T2DM, exercise training programs should be written and delivered 
      by individuals with appropriate qualifications and experience to recognise and 
      accommodate comorbidities and complications.
CI  - Copyright (c) 2011 Sports Medicine Australia. Published by Elsevier Ltd. All rights 
      reserved.
FAU - Hordern, Matthew D
AU  - Hordern MD
AD  - School of Medicine, The University of Queensland, Australia.
FAU - Dunstan, David W
AU  - Dunstan DW
FAU - Prins, Johannes B
AU  - Prins JB
FAU - Baker, Michael K
AU  - Baker MK
FAU - Singh, Maria A Fiatarone
AU  - Singh MA
FAU - Coombes, Jeff S
AU  - Coombes JS
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PT  - Review
DEP - 20110528
PL  - Australia
TA  - J Sci Med Sport
JT  - Journal of science and medicine in sport
JID - 9812598
SB  - IM
MH  - Australia
MH  - Diabetes Mellitus, Type 2/*therapy
MH  - *Exercise Therapy
MH  - Humans
MH  - Prediabetic State/physiopathology/*therapy
MH  - Sports Medicine
EDAT- 2011/05/31 06:00
MHDA- 2012/05/12 06:00
CRDT- 2011/05/31 06:00
PHST- 2011/03/05 00:00 [received]
PHST- 2011/04/28 00:00 [revised]
PHST- 2011/04/29 00:00 [accepted]
PHST- 2011/05/31 06:00 [entrez]
PHST- 2011/05/31 06:00 [pubmed]
PHST- 2012/05/12 06:00 [medline]
AID - S1440-2440(11)00080-6 [pii]
AID - 10.1016/j.jsams.2011.04.005 [doi]
PST - ppublish
SO  - J Sci Med Sport. 2012 Jan;15(1):25-31. doi: 10.1016/j.jsams.2011.04.005. Epub 
      2011 May 28.